References
- Astrup T. Blood clotting and related processes. Adv. Enzym. 1950; 40: 1
- Astrup T., Müllertz S., Hansen J. R. The value of Owren's method of estimating prothrombin. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 209
- Biggs R., Macfarlane R. G. Estimation of prothrombin in dicoumarin therapy. J. Clin. Path. 1949; 2: 33
- Conley C. L., Morse W. I. Thromboplastic factors in the estimation of prothrombin concentrations. Am. J. M. Sc. 1948; 215: 158
- Frommeyer W. B., Jr. Determination of prothrombin by the dilution method. Stability and activity of human and bovine prothrombin-free plasma. J. Lab. & Clin. Med. 1949; 34: 1356
- Koller F., Loeliger A., Duckert F. Experimens on a new clotting factor (factor VII). Acta hsematol. 1951; 6: 1
- Larsen E. H. The alterations of the prothrombin activity in the newborn. Copenhagen 1952, Diss
- Legler R. G. Über die Kinetik der Blutgeninnung. I. Helv. Chim. Acta 1943; 26: 1512
- Owren P. A. New investigation on the coagulation of blood. Arbok for det Norske Viden-skapsakademi. Oslo 1944; 21
- Owren P. A. The coagulation of blood. Investigations on a new clotting factor. Acta Med. Scandinav. 1947a, Suppl. 194
- Owren P. A. New factors concerned in the coagulation of blood. Bull. l'Acad. Suisse Sci. Med. 1947b; 3: 163
- Owren P. A. A quantitative one-stage method for the assay of prothrombin. Scandinav. J. Clin. & Lab. Investigation 1949a; 1: 81
- Owren P. A. The diagnostic and prognostic significance of plasma prothrombin and factor V levels in parenchymatous hepatitis and obstructive jaundice. Scandinav. J. Clin. & Lab. Investigation 1949b; 1: 131
- Owren P. A. Proconvertin, the new clotting factor. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 168
- Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 201
- Quick A. J. The nature of the bleeding in jaundice. J. A. M. A. 1938; 110: 1658
- Quick A. J. Determination of prothrombin. Proc. Soc. Exper. Biol. & Med. 1939; 42: 788
- Quick A. J. On constitution of prothrombin. Am. J. Physiol. 1943; 140: 212
- Quick A. J. On the quantitative estimation of prothrombin. Am. J. Clin. Path. 1945; 15: 500
- Quick A. J. Components of the prothrombin complex. Am. J. Physiol. 1947; 151: 63
- Quick A J., Stefaninii M. Effect of dicumarol on concentration of the labile factor. Proc. Soc. Exper. Biol. & Med. 1949; 72: 232
- Rapoport S. New formula for dilution curve of plasma prothrombin. Normal standards and changes in pathological conditions. Proc. Soc. Exper. Biol. & Med. 1947; 64: 478
- Rosenfield R. E., Tuft H. S. Estimation of prothrombin level from prothrombin time. Am. J. Clin. Path. 1947; 17: 40S
- Sørbye Ø., Kruse I., Dam H. The factor in vitamin K-deficient plasma, which accelerates the coagulation of dicumarol plasma. Acta chem. Scandinav. 1950; 4: 549
- Blood Clotting and Allied Problems. Transactions of the First, Second and Third Conference. Josiah Macy, Jr. Foundation, New York 1948, 1949, 1950
- Valentine E., Reinold J., Schneider E. The effectiveness of prenatal administration of 2-methyl-1,4-naphtoquinon in maintaining normal prothrombin levels in infants. Am. J. M. Sc. 1941; 202: 359
- Ware A. G., Seegers W. H. Serum Ac. globulin: formation from plasma Ac-globulin; role in blood coagulation; partial purification; properties; and quantitative determination. Am. J. Physiol. 1948; 152: 567
- De Vries A., Alexander B., Goldstein R. A factor in serum, which accelerates the conversion of prothrombin to thrombin. I. Its determination and some physiological and biochemical properties. Blood 1949; 4: 247
- Ziffren S. E., Owen C. A., Hoffman G. R., Smith H. P. A simple bedside test for control of vitamin K therapy. Am. J. Clin. Path. 1940; 10: 13